Johnson & Johnson vs Invesco WilderHill Clean Energy ETF — how do they compare? Johnson & Johnson trades at $249.8 (market cap $598.96B), while Invesco WilderHill Clean Energy ETF trades at $34.17. The key difference: Johnson & Johnson pays a 2.15% dividend while Invesco WilderHill Clean Energy ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | PBW | |
|---|---|---|
Market Cap | $598.96B | — |
Volume | 6,156,228 | — |
Sector | Health | Sector/Thematic |
52-Week High | $267.24 | $46.99 |
52-Week Low | $164.36 | $22.23 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
PBW trades at $33.21, down 0.54% today, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The ETF faces volatility tied to interest rate cycles, with recent news highlighting clean energy sector tailwinds from energy security concerns and data center demand. Key financial ratios are unavailable, limiting fundamental assessment.
Outlook hinges on clean energy policy support and interest rate sensitivity, with risks including sector volatility and competitive ETF performance. The bearish technical stance and rate-driven sell-offs underscore caution, though long-term energy transition trends offer potential upside.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →